Subject: Addiction Treatment
Crossing The Threshold: Navigating The Gateway To SUD Treatment Spaces
This insightful webinar will guide you through the crucial steps in accessing substance use disorder (SUD) treatment spaces.
Drug User Health in a Syndemic Environment
This session addresses challenges related to living and accessing services in a syndemic environment. It covers those strategies that ensure individuals are able to address co-morbidities.
All four 2023 Harm Reduction Conference training sessions must be taken to receive a total of 3.25 credit hours.
Social Justice/Language Justice
This plenary focuses on how to eliminate and replace stigmatizing language and negative bias while also using person-first language within communities of people who struggle with substance use disorder to increase access to services and successful retention in care.
All four 2023 Harm Reduction Conference training sessions must be taken to receive a total of 3.25 credit hours.
National Perspectives on Harm Reduction and Community Health
This session describes the impact of drug use from a national and local perspective, examines the social impact of drug use on communities, and identifies national and local harm reduction activities. Surveillance data will be presented to highlight national and local trends.
All four 2023 Harm Reduction Conference training sessions must be taken to receive a total of 3.25 credit hours.
Understanding and Addressing Stigma and Discrimination in Addiction
This webinar will briefly review the new knowledge gained during the past 50 years. The faculty will describe the shifts in cultural understanding of addiction that have given rise to new research and approaches that can help reduce stigma and discrimination against people with substance use disorders.
Destigmatization of Drug Use
This session explores the impact of stigma on people who have been diagnosed with substance use disorder (SUD) and those who are not clinically diagnosed but display symptoms. The presenter examines the relationship between stigma and systemic racism, as well as racism’s compounding effect on access to healthcare services for people who use drugs. The presenter also provides strategies for challenging stigma and misconceptions about SUD.
TIP 63: Medications for Opioid Use Disorder
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.
The Opioid Crisis and the Black/African American Population: An Urgent Issue
This issue brief presents recent data on prevalence of opioid misuse and death rates in the Black/AA population; contextual factors & challenges to prevention & treatment; innovative outreach & engagement strategies to connect people to evidence-based treatment; and the importance of community voice.
PCSS Resources for Health Professionals, Patients and Community
These resources for treating OUD and chronic pain were developed for health professionals, patients, family members and significant others of patients and the general community to learn more about the evidence-based treatment of opioid use disorders and the treatment of chronic pain.
American Society of Addiction Medicine: Appropriate Use of Drug Testing in Clinical Addiction Medicine
This resource provides guidance about the effective use of drug testing in the identification, diagnosis, treatment, and promotion of recovery for patients with, or at risk for, addiction.